ITGAX and neoplasm: B. breve lw01 administration suppresses head and neck squamous cell carcinoma growth in mice, mediated by the upregulation of CCL20, which is associated with increased migration of CD11c DCs to ileal villi and tumor microenvironment via upregulation of IL-12137.